Pharmaceuticals
-
RECOVERY trial to investigate flu treatments
The Oxford-based RECOVERY trial, which discovered four effective treatments for COVID-19, is to investigate treatments for influenza, it has been announced. Read more
-
New Parkinson’s infusion treatment approved
A treatment that improves uptake of dopamine in patients with advanced Parkinson’s disease has gained approval for use in the NHS in England, it has been announced. Read more
-
Could bipolar disorder be diagnosed with a blood test?
British scientists have identified a biomarker that could distinguish bipolar disorder and major depressive disorder, it has been announced. Read more
-
Biggest boost in cervical cancer care in 20 years announced
A short course of induction chemotherapy may significantly improve survival of patients being treated for cervical cancer, British researchers report today. Read more
-
Hope over gynaecological cancer research findings
Several studies offer hope of significant advance in the care of gynaecological cancers, a major European conference has heard. Read more
-
Women face increased risk of site reactions to vaccine
Women could be more likely to have injection site and systemic reactions to the seasonal flu vaccination than men, Canadian researchers suggests today. Read more
-
Joint injections ‘ineffective’ for hand osteoarthritis
Joint injections are ineffective for relieving the symptoms of hand osteoarthritis and evidence about the effectiveness of topical creams and gels is uncertain, researchers say today. Read more
-
Hope for ‘kinder’ neuroblastoma treatment
Children with neuroblastoma could have the option of treatments with fewer side-effects, British researchers reported last night. Read more
-
Simple blood test for Parkinson’s-related diseases
A newly identified biomarker may help diagnose several types of Parkinson’s-related diseases, Swedish researchers have announced. Read more
-
Blood clot risk on oestrogen measured
The Factor V Leiden gene can combine with other factors to place women at risk when using oestrogen-based drugs, according to a new study. Read more